Despite the abundance of available biomarkers, initial prostate specific antigen (PSA) and anaemia reflect the only laboratory biomarkers for overall survival (OS) next to presence of visceral metastases, pain, and bone scan progression in metastatic PC with docetaxel treatment [2]. The gene discussed is KLK3; the disease is anemia.